Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Clinical trial NCT03740256 · RECRUITING

Trial details

NCT number: NCT03740256
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Cancer Head and Neck Squamous Cell Carcinoma Cancer of the Salivary Gland Lung Cancer Breast Cancer Gastric Cancer Esophageal Cancer Colorectal Cancer Pancreatic Adenocarcinoma Solid Tumor

Start date: 2020-12-14
Primary completion: 2026-12-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.